Search Results - "Saga, Inger Marie"

Impact of the Serogroup A Meningococcal Conjugate Vaccine, MenAfriVac, on Carriage and Herd Immunity by Kristiansen, Paul A., Diomandé, Fabien, Ba, Absatou Ky, Sanou, Idrissa, Ouédraogo, Abdoul—Salam, Ouédraogo, Rasmata, Sangaré, Lassana, Kandolo, Denis, Aké, Flavien, Saga, Inger Marie, Clark, Thomas A., Misegades, Lara, Martin, Stacey W., Thomas, Jennifer Dolan, Tiendrebeogo, Sylvestre R., Hassan-King, Musa, Djingarey, Mamoudou H., Messonnier, Nancy E., Préziosi, Marie-Pierre, LaForce, F. Marc, Caugant, Dominique A.

“…Background. The conjugate vaccine against serogroup A Neisseria meningitidis (NmA), MenAfriVac, was first introduced in mass vaccination campaigns of…”
Get full text

Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac by Kristiansen, Paul A, Ba, Absatou Ky, Ouédraogo, Abdoul-Salam, Sanou, Idrissa, Ouédraogo, Rasmata, Sangaré, Lassana, Diomandé, Fabien, Kandolo, Denis, Saga, Inger Marie, Misegades, Lara, Clark, Thomas A, Préziosi, Marie-Pierre, Caugant, Dominique A

“…The conjugate vaccine against serogroup A Neisseria meningitidis (NmA), MenAfriVac, is currently being introduced throughout the African meningitis belt. In…”
Get full text

Persistent low carriage of serogroup A Neisseria meningitidistwo years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac by Kristiansen, Paul A, Ba, Absatou Ky, Ouñdraogo, Abdoul-Salam, Sanou, Idrissa, Ouñdraogo, Rasmata, Sangarñ, Lassana, Diomandñ, Fabien, Kandolo, Denis, Saga, Inger Marie, Misegades, Lara, Clark, Thomas A, Prñziosi, Marie-Pierre, Caugant, Dominique A

“…The conjugate vaccine against serogroup A Neisseria meningitidis (NmA), MenAfriVac, is currently being introduced throughout the African meningitis belt. In…”
Get full text